Pediatric Endocrinology

A treatment targeting T-cell metabolism could reinvigorate immune tolerance mechanisms to combat autoimmune disease and transplant rejection, Vanderbilt researchers discovered. Read More

Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity. Read More

Jill Simmons, M.D., encounters medical mysteries that have the makings of a science fiction film or novel. Read More

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D. Read More

A patient comfort protocol is rendering minor procedures less painful and upsetting for younger outpatients of the Monroe Carell Jr. Children’s Hospital at Vanderbilt. Read More

Janelly Martinez-Amador was born with thin, fragile bones, and by 3, she had no visible bones on X-rays. Initially, doctors weren’t sure she would survive her first birthday. Read More

Middle Tennessee’s latest celebrities are the 11-and-12-year-old Little League U.S. World Series Champions from Goodlettesville. But one young player already had quite a fan base built up at a Vanderbilt pediatric diabetes clinic, where he has been a patient most of his life. Luke Brown and his family are also… Read More

Left to right: Karen Gregory, Elizabeth Hammock, Peilin Jia, John Panos Eight Vanderbilt University scientists have won 2010 Young Investigator Awards from NARSAD, the world’s leading mental health research charity. Each scientist will receive up to $60,000 over two years for innovative brain and behavioral studies of serious psychiatric disorders. Read More